Daxxify, a new anti-wrinkle drug, approved by the FDA is expected to rival Botox, which has dominated the market for decades. Daxxify injections last up to 6 months for many people – twice as long as the other products on the market. Its manufacturer, Revance, has not yet released pricing information. The drug is expected to hit the market in 2023.
https://www.phillyvoice.com/anti-wrinkle-drugs-botox-daxxify-/